Abstract-The initial step of thrombus formation on blood-contacting biomaterials is known to be adsorption of blood proteins followed by platelet adhesion. Poly(ethylene oxide) (PEO) has been frequently used to modify biomaterial surfaces to minimize or prevent protein adsorption and cell adhesion. PEO was grafted onto a number of biomaterials in our laboratory. Nitinol stents and glass tubes were grafted with PEO by priming the metal surface with trichlorovinylsilane(TCVS) followed by adsorption of Pluronic and°-irradiation. Nitinol stents were also coated with Carbothane ® for PEO grafting. Chemically inert polymeric biomaterials, such as Carbothane, polyethylene, silicone rubber, and expanded polytetra uoroethylene (e-PTFE), were rst adsorbed with PEO -polybutadiene-PEO (PEO -PB -PEO) triblock copolymers and then exposed to°-irradiation for covalent grafting. For PEO grafting to Dacron ® (polyethylene terephthalate), the surface was sequentially treated with PEO -PB -PEO and Pluronics ® followed by°-irradiation.
PEO monolayer overcoming its repulsive property. Our studies indicate that the testing of in vitro platelet adhesion should include adhesion of large platelet aggregates, in addition to adhesion of individual platelets. Furthermore, the surface modi cation methods should be improved over the current monolayer grafting concept so that the repulsive force by the grafted PEO layers is large enough to prevent adhesion of platelet aggregates formed in the bulk blood before arriving at the biomaterial surface.
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INTRODUCION
Biomaterials have been used in various clinical applications. Blood-contacting biomaterials range from coronary stent to total arti cial heart. One of the most important problems associated with blood-contacting biomaterials is surface-induced thrombus formation. The sequence of thrombus formation has been well established [1] . The rst event occurring after exposure of biomaterials to blood is the adsorption of blood proteins. The types and the amounts of the adsorbed proteins determine whether platelets will adhere and activate or not. Adsorption of platelet-adhesive proteins, such as brinogen, leads to adhesion and activation of platelets. The initial layer of activated platelets attract more platelets to form thrombus. Thrombi are embolized and the whole sequence may be repeated. Since the thrombus formation begins with the adsorption of proteins and platelets, efforts have been directed toward controlling (mainly preventing) protein adsorption and platelet adhesion. Growing endothelial cells on biomaterials appears to be the most ideal solution for making truly blood-compatible materials. Human endothelial cells, however, have been particularly dif cult to grow [2, 3] . Since protein adsorption and platelet adhesion are interfacial phenomena, the surface properties of biomaterials determine the thrombogenicity. For this reason, modi cation of the biomaterial surfaces with protein-repulsive molecules has become an important alternative for making more blood compatible materials.
The commonly used protein-repulsive molecules are proteins such as albumin [4, 5] , polysaccharides such as heparin [6, 7] and dextran [8] , synthetic polymers such as PEO [9, 10] phospholipid molecules such as phosphatidyl choline [11] , and surface active molecules such as self-assembled monolayers [12] . Surface modication of biomaterials with these macromolecules makes theoretical sense, since the interfacial properties depend on the outer few layers of biomaterials. The surface modi cation approach has been quite successful, at least in in vitro experiments in prevention of protein adsorption and platelet adhesion. The ex vivo / in vivo applications of surface-modi ed biomaterials, however, have not met the expectations. The inability of in vitro results to predict the in vivo performance has been the bottleneck in the development of improved biomaterials, and has delayed rational design of biomaterial surfaces. We have developed a number of approaches for grafting PEO to various biomaterial surfaces, and the PEO-grafted materials were tested in vitro using brinogen adsorption and platelet adhesion [13] [14] [15] [16] [17] [18] [19] . The PEO-grafted materials were also tested ex vivo / in vivo in three different laboratories using different animal models [20] [21] [22] . This paper compares the results of those studies to gain new insights into the ex vivo / in vivo thrombogenicity of PEO-grafted biomaterials.
SURFACE MODIFICATION OF BIOMATERIALS WITH PEO

Synthesis of PEO-PB-PEO triblock copolymers
PEO -polybutadiene-PEO (PEO -PB -PEO) triblock copolymers with various molecular weights of PEO were used for grafting of PEO to different biomaterials. PEO -PB -PEO copolymers were synthesized as described previously [16] . Brie y, poly(ethylene oxide) methyl ether (m-PEO) was azeotropically dried in benzene, and the dry m-PEO in THF (15%) was added dropwise to the hydroxyl terminated PB solution (15% w/v in tetrahydrofuran). After stirring for 48 h under dry nitrogen, the reaction product was twice precipitated from THF with hexane and dried in vacuum. The molecular weight of the PB moiety of the copolymer was 700 g mol ¡1 . The molecular weight of the PEO chain was either 350 or 5000. Notations of 'COP350' and 'COP5000' were used to indicate the copolymers with PEO molecular weights of 350 and 5000.
PEO grafting on nitinol stents
Two types of nitinol stents (HARTS ® and Act-One ® Progressive Angioplasty Systems, Inc., Menlo Park, CA, USA) were grafted with PEO. The stents were made of 7-or 15-mm long slotted tubes with nominal strut thickness of 0.006 in. The stents were cleaned by soaking in 1% sodium dodecylsulfate (SDS) solution with vortexing for 5 min followed by rinsing in deionized distilled water (DDW) and sonicating for 10 min in fresh DDW. The cleaned HARTS stents were silanized by immersing in a solution of 5% trichlorovinylsilane (TCVS, Aldrich, Milwaukee, WI, USA) in chloroform (analytical grade, Mallinkrodt, Paris, KY, USA) at room temperature. After 3 h they were rinsed sequentially in fresh chloroform, absolute ethanol, and DDW. The silanized stents were exposed to Pluronic ® F108 (PF108) or Pluronic ® F127 (PF127) at the concentration of 1 mg ml ¡1 . (PF108 and PF127 are PEO/poly(propylene oxide)/ PEO triblock copolymers with the repeating monomer units of 128/54/128 and 98/67/98, respectively.) After 1 h the whole system in DDW was exposed to 0.3 Mrad°-radiation from 60 Co irradiator. The samples were then washed in 1% SDS overnight and rinsed thoroughly with DDW. They were dried at 60 ± C and stored covered at room temperature until use. Act-One stents were grafted with PEO using a different method. Each stent was mounted on the mandrel of a motor and rotated at 600 rpm. The 6 ml of 1% Carbothane ® solution was spread onto the top of water at a rate of 1 ml min ¡1 and the stent was introduced through the polymer layer into water to form a thin porous polymer membrane. The porous membrane was made for applications of localized drug delivery in other studies. The coated stents were then immersed in 1 mg ml ¡1 of COP5000 for 1 h before°-irradiation for 2.5 Mrad. After irradiation stents were rinsed three times in water and collapsed in water at 70 ± C prior to vacuum drying.
PEO grafting on glass tubes
Glass tubes (inner diameter (i.d.) 4 mm, Dow Corning, Midland, MI, USA) were cleaned by immersion in chromic-sulfuric acid solution overnight, rinsed with copious DDW and dried at 60 ± C. Glass surface was silanized by the same procedure used for nitinol stents and grafted with COP5000 [21] . were cleaned by washing with running DDW for 1 h. They were grafted with PEO using COP5000 [21] . The copolymer solution at a concentration of 1 mg ml ¡1 was introduced inside the tubing and after 2 h at room temperature, the whole system was exposed to°-radiation for a total radiation dose of 1 Mrad [21] . The presence of the copolymer in the bulk solution during exposure to°-radiation resulted in higher grafting ef ciency compared to exposure to°-radiation after washing bulk copolymer solution. After°-irradiation, the grafted surface was incubated with 1% SDS solution overnight and rinsed thoroughly with DDW to remove COP5000 molecules that were not covalently linked to the biomaterial surface. The outer surface of the ePTFE graft was sealed with adhesive silicone (NuSil ® , Type A, Silicone Technology, Carpinteria, CA, USA) to prevent leakage.
PEO
Albumin adsorption on plasticized poly(vinyl chloride) tubing
Plasticized poly(vinyl chloride) (Tygon ® , i.d. 3.175 mm, o.d. 6.35 mm, Norton Plastics, Akron, OH, USA) tubing was used as a connector for the test tubes of a series shunt in acute canine ex vivo experiments. Tygon tubing was rst cleaned with 0.1% Ivory detergent solution at room temperature and rinsed with running DDW. The inner surfaces of only Tygon tubes were exposed to albumin solution at a concentration of 10 mg ml ¡1 for 2 h. The bulk albumin solution was rinsed by ushing the tubes with PBS. Albumin coated tubes were kept at 4 ± C until use.
Surface modi cation of Dacron
Dacron ® poly(ethylene terephthalate) fabric (DuPont, Wilmington, DE, USA) was cleaned by stirring in a 2% Isoclean solution (Isolab, Akron, OH, USA) at 80 ± C for 2 h and rinsing in copious amount of DDW and in boiling DDW for 2 h. The clean fabric was placed in water and vacuum degassed for 1 h to displace air from the inter-ber spaces. The degassed fabric was stirred in the COP350 solution (10 mg ml ¡1 ) at room temperature for 4 h. The COP350-primed Dacron fabric was brie y rinsed in DDW, and placed in a PF108 solution at bulk concentration of 5 mg ml ¡1 . The solution was stirred at room temperature for 1 h to allow adsorption of PF108 to the priming layer. The PF108 solution containing the primed Dacron fabric was subjected to°-radiation at room temperature for a total dose of 0.8 Mrad. After°-irradiation, the fabric was placed in 1% SDS solution overnight to remove ungrafted molecules, rinsed with DDW several times by vortexing, and dried at 55 ± C in an oven [19] . The PEO-grafted Dacron fabric was assembled on the 25-mm titanium-stem of Medtronic-Hall heart valve (Medtronic Inc., Heart Valve Division). Valves with PEO-grafted sewing rings were used for an in vivo study [22] .
In vitro brinogen adsorption
Commercial human and canine brinogen (Fraction I, Sigma, St. Louis, MO, USA) were puri ed by the method of Laki [23, 24] . Fibrinogen was radiolabeled with 125 I using the Iodo-Gen reagent (Pierce, Rockford, IL, USA), and the radiolabeled brinogen was mixed with native brinogen in the weight ratio of 1 : 40. The nal brinogen concentration was 0.1 mg ml ¡1 . Fibrinogen was allowed to adsorb for 1 h at room temperature, and the surface bound radioactivity was measured on a°-scintillation counter (Beckman, Gamma 5500B, Arlington Heights, IL, USA).
In vitro platelet adhesion
Human and canine blood were collected in heparinized tubes and the platelet-richplasma (PRP) was separated by centrifuging at 100 g for 10 min. The PRP was collected and kept in a water bath at 37 ± C for 30 min. The packed cell fraction was discarded. PEO-grafted samples, previously hydrated in PBS for 1 h, were immersed in aliquots of the PRP. During the 1 h exposure time the test tubes containing the samples were kept on a rotator. They were rinsed with PBS to remove non-adherent platelets, xed with 2% glutaraldehyde (Sigma, St. Louis, MO, USA) dehydrated in a graded ethanol series, and critical point dried. The dehydrated samples were examined on a scanning electron microscope (SEM) (JSM-840, Joel Inc., Tokyo, Japan). Platelets were also labeled with rhodamine-phalloidin for observation by a video-intensi ed uorescence microscope [25] .
Porcine extracorporeal arteriovenous shunt experiment
Stent thrombosis was examined using a model based on the porcine carotidjugular arteriovenous extracorporeal perfusion system by Badimon et al. [26] . Pigs weighing 24-31 kg were fasted overnight and sedated with 1% ketamine and 1% xylazine. Anesthesia was maintained with 1% iso urane. An extracorporeal circuit was established by cannulating the carotid artery and internal jugular vein. Body temperature was maintained at 37 ± C using a thermal blanket. Stents were expanded using a mandrel and mounted in a 2-mm diameter perfusion chamber [26] . A strip of porcine aorta (1.0 £ 2.5 cm) with an intact internal elastic laminar was placed in contact with approximately third of the outer circumference of the stent serving as a water-tight seal between two halves of the chamber. The arterial cannula was connected to the inlet of the chamber and the out ow line returned blood to the jugular vein through a variable speed peristaltic pump (Master ex model 7518-110 Cole-Palmer Instrument Co.). The chamber was placed in a 37 ± C water bath. A transit time Doppler ow probe (Transonic System Inc., Ithaca, NY, USA) was interposed after the pump to record ow. The patency of vascular catheters was maintained by injecting 20 U kg ¡1 heparin to the pigs. Such low doses of administered heparin did not have any effect on stent thrombosis in the porcine model used at the shear rates examined [27] . Pigs received 325 mg of aspirin by oral administration the day prior to the procedure.
The effects of surgical stress was minimized by allowing 60 min of a stabilization period. Then the chamber was perfused with Krebs buffer solution for 1 min. Blood ow through the circuit containing a stent sample was established at a predetermined ow rate. After a timed interval, the circuit was washed with the buffer for 30 s, and the stent was removed for analysis. New stents were inserted to the chamber after cleaning for subsequent perfusion experiments. The shear rate was approximately 1500 s ¡1 . The extent of stent thrombosis was assessed by measuring the weights of dry thrombi.
Porcine mechanical heart valve implantation study
Mechanical heart valves with PEO-grafted sewing rings were implanted into Yorkshire-cross pigs weighing 35-45 kg [22, 28] . The arterial and venous lines were connected to the components of the cardiopulmonary bypass (CPB) circuit. During CPB, systemic heparinization was maintained by 3 mg kg ¡1 intravenous injection. Once the heart was arrested, the left atrial appendage was incised and mitral valve was removed. After the prosthetic valve was inserted, the heart was rewarmed, deaired, and de brillated.
111 In-labeled platelets were introduced into the blood stream after the pigs were removed from cardiopulmonary bypass circuit. Blood samples were collected at timed intervals up to 24 h to monitor the platelet radioactivity and free 111 In in plasma. Protamine sulfate was administered to reverse the heparin activity. At the end of each experiment, the pig was sacri ced to remove mechanical heart valve.
Acute canine ex vivo series shunt experiment
Adult mongrel dogs weighing 50-60 lb were used in the canine experiments [21] . The designated animal was injected with 10 ml of 111 In-labeled platelets 20 h prior to placement of the shunt. Each animal was fasted for 20 h prior to surgery. A series shunt was constructed by connecting 6-cm segments of vascular grafts through Tygon spacers. Each series shunt consisted of PEO-grafted and control graft tubes randomly positioned along the shunt. Shunts were prepared 1 day before surgery and kept lled with PBS at 4 ± C. The animal with the implanted shunt was positioned under a large eld-of-view scintillation camera (Sigma 410 Radioisotope Camera, Ohio Nuclear Inc., Solon, OH, USA) tted with a high resolution Collimator and connected to a digital computer. All animals were imaged for 2 h after the start of blood ow through the shunt. At the end of the 2 h, the artery and vein were clamped and the shunt ushed by injecting 30 ml PBS through the ush port. This was followed by injection of 30 ml of 2% glutaraldehyde in PBS to x the platelets and other blood cells that were adherent to the graft material surface. The raw°-count was divided by the platelet speci c activity and the graft surface area to get the number of platelets deposited in number of platelets per cm 2 . All animal experiments adhered to the principles in the guidelines of the American Physiologic Society and the Guide for the Care and Use of Laboratory Animals (NIH publication #96-23, 1996), and were approved by the Institutional Animal Use and Care Committee of the participating institutions.
RESULTS
In vitro studies
The PEO-grafted biomaterials were tested in vitro for their potential to inhibit brinogen adsorption and platelet adhesion. The results obtained from a number of studies are listed in Table 1 . Table 1 is divided into three categories based on the biomaterials used in ex vivo / in vivo experiments. When PEO-grafted nitinol stents were tested in vitro, brinogen adsorption was reduced for more than 88% from 0:50 § 0:01 to 0:06 § 0:01 ¹g cm ¡2 [29] . On the control nitinol stents, numerous platelet aggregates covered the entire surface. Platelets on the bottoms of the aggregates were fully spread. On the PEO-grafted nitinol stents, however, only a small portion of the surface was covered with individual platelets which were only contact adherent. Apparently, platelets could not spread at all.
Several materials that could be used as vascular grafts were modi ed with PEO [21] . The amount of the adsorbed brinogen on control surfaces were 0:25 § 0:01, 0:34 § 0:04, 0:37 § 0:04, and 0:36 § 0:06 ¹g cm ¡2 for glass, Silastic ® , polyethylene, and e-PTFE, respectively. The surface brinogen concentrations were about the same for polymers, and only the hydrophilic glass showed lower surface brinogen concentration. PEO grafting reduced the surface brinogen concentration to less than 0.1 ¹g cm ¡2 for Silastic and polyethylene. The brinogen adsorption on PEO-grafted glass was almost negligible. The reduction in brinogen adsorption on e-PTFE by PEO grafting was not as noticeable as on other surfaces. PEO grafting reduced the surface brinogen concentration to 0.25 ¹g cm ¡2 , which was still high enough to attract and activate platelets. Apparently, PEO grafting to e-PTFE was not as effective as on other biomaterials. The results of platelet adhesion study were correlated with those of platelet adhesion study. On control glass, Silastic, and polyethylene, platelets adhered and fully activated. Platelets underwent shape change to a spread, round form, and many granules released from the activated platelets were observable. On the PEO-grafted surfaces, however, platelet adhesion was almost completely prevented. Even when a few platelets were adhered, they remained spherical and could not spread on the surface. On e-PTFE, however, platelets were able to adhere to the surface and form aggregates whether the surface was PEO-grafted or not. Many such aggregates were observed throughout the surface. The lack of the ability to prevent platelet adhesion and aggregation on PEO-grafted e-PTFE can be predicted from the lack of the ability to prevent brinogen adsorption. It is pointed out that the albumin-coated plasticized PVC (Tygon ® ) was able to prevent brinogen adsorption and platelet adhesion. The surface brinogen concentration on Dacron ® fabric was 0:59 § 0:04 ¹g cm ¡2 , but the true value may be different since the surface area of the fabric used for calculation was the nominal value [19] . The value, however, served as a good reference point. PEO grafting reduced the surface concentration to 0:07 § 0:04 ¹g cm ¡2 . This was almost 90% decrease. Platelet adhesion re ected the results of the brinogen adsorption. No platelets could adhere to PEO-grafted Dacron fabric, while many platelet aggregates were formed on the control Dacron fabric.
The common feature of the data listed in Table 1 is that the brinogen adsorption results closely re ect the platelet adhesion results. Whenever the surface brinogen concentration was less than 0.1 ¹g cm ¡2 , platelet adhesion was prevented. The reduction in brinogen adsorption of around 80% or more resulted in prevention of platelet adhesion. Please note that the surface brinogen concentration of 0.1 ¹g cm ¡2 was obtained when the surface was exposed to a unary brinogen solution. When the PEO-grafted surface is exposed to a complex protein mixture, such as PRP, the surface brinogen concentration will be much smaller than the minimum surface brinogen concentration necessary for adhesion and activation of platelets, which was 0.02 ¹g cm ¡2 [30] .
Ex vivo/in vivo studies
PEO-grafted biomaterials were tested in three different animal experiments and the results are shown in Table 2 . In a porcine extracorporeal arteriovenous shunt study, the thrombus weights on the unpolished and PEO-grafted nitinol stents were 14:0 § 3:8 (n D 13) and 1:0 § 0:5 mg (n D 6), respectively. This is more than 90% decrease in the thrombus weight by PEO grafting. PEO-grafted stents reduced stent thrombogenicity dramatically. It is noted here that this ex vivo study does not stimulate underlying vascular injury of native vessels that can signi cantly affect the stent thrombosis. In the canine ex vivo series shunt experiments, PEO-grafted shunts showed only moderate decrease in platelet deposition. Decreases in the average values of platelet deposition by PEO grafting were 37, 35, 36, and 37% for glass, Silastic ® , polyethylene, and e-PTFE, respectively. This relative decrease appears to be the same for all the materials tested, but there are two important points to be made. First, there is no statistically signi cant differences in platelet deposition between the control and PEO-grafted samples, except for on e-PTFE (p D 0:01). Thus, it can be said that there may not be any real bene cial impact of the PEO-grafting. Second, platelet depositions on the control glass, Silastic ® , and polyethylene were only 38 § 12, 200 § 110, and 330 § 110 platelets per 10 3 ¹m 2 , respectively. These values indicate that thrombus formation on the glass was negligible, and that on Silastic ® and polyethylene was only moderate. Only small portions of the surfaces was covered with platelet thrombi. Platelet depositions on control and PEO-grafted e-PTFE were unacceptable. Platelet deposition at the level of 5000 platelets per Mechanical heart valves (in porcine mechanical heart valve implantation experiments) Dacron ® sewing ring Control 0.09 § 0:06% (the percentage of the injected radioactivity of 111 Inlabeled platelet) PEO-grafted 0.21 § 0:21% (the percentage of the injected radioactivity of 111 Inlabeled platelet)
Some of the data were obtained from refs [1, 21, 22] . 10 3 ¹m 2 means formation of many, huge thrombi on the surface. Since the surface brinogen concentration on PEO-grafted e-PTFE is still very high (0.25 ¹g cm ¡2 in Table 1 ), formation of numerous thrombi on PEO-grafted e-PTFE is not surprising. Unlike the results observed with the nitinol stents, the effects of PEO grafting on glass, Silastic ® , polyethylene, and e-PTFE were neither signi cant nor dramatic. It is interesting to note that the platelet deposition was almost none on albumincoated Tygon ® . Albumin may be a better choice for preventing thrombus formation on many biomaterials, and this is not surprising considering the highly bene cial effect of albumin coating in both in vitro and ex vivo experiments [1, 4, [31] [32] [33] [34] .
Platelet deposition on the PEO-grafted Dacron ® sewing ring of a mechanical heart valve was not any better than that on the control surface. Platelet deposition on the control Dacron ® sewing ring was 0:09 § 0:06% of the total radioactivity of 111 Inlabeled platelets injected into the blood. On the other hand, platelet deposition on the PEO-grafted sewing ring was 0:21 § 0:21%. Some PEO-grafted sewing rings had much less thrombus formation, but the others showed signi cantly more thrombus. PEO grafting either reduced thrombus formation to an insigni cant level or made the surface much worse than the control surface. These contradicting results are expected to be due to the factors other than PEO grafting, since the effect of PEO grafting, whatever it may be, should be consistent.
DISCUSSION
The in vitro testing of brinogen adsorption and platelet adhesion has been traditionally used for examining potentials of PEO-grafted biomaterials as well as biomaterials grafted with other molecules. Using the two parameters as the criteria is theoretically sound, since brinogen adsorption and platelet adhesion are the rst events occurring upon exposure of biomaterials to blood. PEO-grafted biomaterials have been tested in vitro using the two parameters in our study. Fibrinogen adsorption and platelet adhesion on most of the PEO-grafted materials have been reduced by more than 90%. As shown in Table 1 , PEO grafting always resulted in signi cant reduction of brinogen adsorption and platelet adhesion. Such good in vitro results, however, were not always translated into good in vivo performances of the biomaterials. As shown in Table 2 , PEO-grafting reduced thrombus formation by more than 90% in a porcine extracorporeal arteriovenous shunt model. The effects of PEO grafting on glass, Silastic ® , and polyethylene were not quite obvious, probably due to the low thrombogenic properties of the control surfaces. No effect of PEO grafting was observed on e-PTFE. This was mostly likely due to inadequate grafting of PEO to e-PTFE, as shown by no reduction of brinogen adsorption and platelet adhesion (Table 1) . Animal experiments of PEO-grafted Dacron ® fabric also showed no consistent, bene cial effect of PEO grafting. The comparison of the results of three different ex vivo / in vivo experiments strongly suggests that the ex vivo / in vivo performances of PEO-grafted biomaterials can be in uenced by factors other than those related to PEO grafting, such as the density, chain length, and exibility of the grafted PEO.
The lack of correlation between in vitro results and ex vivo/in vivo performances is not easy to understand. One way of nding the answer for this question may be to compare the experimental conditions between in vitro and ex vivo/in vivo experiments. In vitro experiments usually do not include shear ow, but this does not seem to be a factor, since the thrombus formation on the nitinol stents was reduced by PEO grafting even when they were tested under shear ow condition in pigs. This also eliminates the possibility of any potential effects of blood shear ow on the grafted PEO molecules, such as conformational change and subsequent repulsive property of the grafted PEO molecules. One important difference in experimental conditions is the presence of anticoagulants in most in vitro experiments. In ex vivo/in vivo experiments, use of anticoagulants varies from laboratory to laboratory. Since anticoagulants have signi cant effects on platelet activation, it is something to be examined further in more detail. In clinical practices, surface-induced thrombosis can be minimized by using antiplatelet agents. For example, the stent thrombosis rate after intracoronary stenting is very low with the use of antiplatelet agents [35, 36] . The acute stent thrombosis under high shear ow conditions was also inhibited in a dose-dependent manner by monoclonal antibody to platelet GP IIb/IIIa receptor [37, 38] or GP IIb/IIIa antagonists [39] . These observations suggest that the biomaterial surface may not be the sole origin for the generation of mural thrombi. In addition to the surfaceinduced platelet activation leading to thrombus formation, it is highly likely that thrombi formed in the bulk blood adsorb to the surface.
The surface-grafted PEO monolayers can effectively prevent adsorption of proteins and individual platelets, as shown in Table 1 and by numerous experiments in the literature. The PEO monolayer, however, may not exert enough repulsive force to prevent adhesion of platelet aggregates that are formed in the bulk blood. The attractive interaction between platelet aggregates and the surface, which increases linearly with the size of aggregates, may be too large for the grafted PEO monolayer. In our previous study, we have shown that PEO chains can have attraction with hydrophobic surfaces [40, 41] . Others have also shown that PEO has af nity, even though weak, to the hydrophobic surface [42] . Platelet aggregates, due to their large size, can push the grafted PEO layer to the surface resulting in attractive interactions between collapsed PEO chains and the hydrophobic surface.
It is not too dif cult to nd out the sources of platelet aggregation in the bulk blood. Many mediators of platelet activation and aggregation accumulate at sites of vascular injury, including thromboxane A 2 , serotonin, ADP, platelet activating factor, thrombin, oxygen-derived free radicals, and tissue factor [43] . Tissue injury has been related to thrombogenicity of implanted stents [44, 45] . Tissue damage resulting from surgical incision is a factor that has not been compared when the data of animal experiments are compared. The absence of any bene cial effect observed with mechanical heart valve in Table 2 may be a direct result of the tissue damage causing platelet aggregate formation in the blood. This can explain the platelet deposition to PEO-grafted sewing ring of a mechanical heart valve with such a large deviation. When the tissue damage is signi cant, it can override the effect of PEO grafting. Otherwise, we can still have the bene cial effect of PEO grafting. Excellent and moderate effect of PEO grafting was observed with nitinol stents and polymer shunts in Table 2 can be explained by the less tissue damage during the experimental procedures. The best method of testing biocompatibility of biomaterials is known to be testing them in ex vivo / in vivo experiments. However, if the surgical procedures are not controlled, i.e. if the tissue damages are not controlled, the results may vary and this makes comparison of the ex vivo / in vivo data dif cult. The use of anticoagulants and/or antiplatelet agents also has to be carefully controlled to evaluate the pure material effect on thrombosis. Different agents inhibit platelet activation differently. Aspirin prevents platelet aggregation by inhibiting the cyclo-oxygenase enzyme, while ticlopidine interferes with ADPdependent platelet activation [46] . Each of these agents can be effective in ex vivo / in vivo studies only in response to speci c aggregatory agents dependent on these mediators. Thus, depending on anticoagulants and/or antiplatelet agents used, the experimental results may be different.
Our hypothesis that the adhesion of platelet aggregates formed in the bulk blood is responsible for causing thrombus formation on PEO-grafted biomaterials surfaces, can explain the discrepancies between in vitro results and ex vivo / in vivo performances of many surface modi ed biomaterials. This hypothesis also provides a new insight into rational development of biomaterials. Biomaterials modi ed with PEO, albumin, heparin, and others have to be tested using platelet aggregates rather than individual platelets. This may more closely represent the situation in animal experiments. The surface modi cation approaches that have been applied to date need to be changed so that the repulsive forces of the grafted layer should be high enough to prevent adhesion of platelet aggregates. Theoretical calculations of the attractive interaction energies between the biomaterial surface and platelets / platelet aggregates would also provide valuable information for the development of better biomaterials.
